Hepcinat LP

✅ Treats Hepatitis C
✅ High success rate
✅ Shortens treatment duration
✅ Lowers risk of liver damage
✅ Improves liver function

Hepcinat LP contains Ledipasvir + Sofosbuvir.

SKU Hepcinat Lp Category Tags , ,

Product Overview

Hepcinat LP is a revolutionary medication formulated to combat hepatitis C virus (HCV) infection. This tablet contains a powerful combination of Ledipasvir (90 mg) and Sofosbuvir (400 mg), two potent antiviral agents that work synergistically to eradicate HCV from the body. Hepcinat LP offers a convenient once-daily dosing regimen, revolutionizing the treatment landscape for chronic hepatitis C.


Hepcinat LP is indicated for the treatment of chronic hepatitis C genotype 1, 4, 5, or 6 infections in adults. It is highly effective in achieving sustained virologic response (SVR), leading to the clearance of HCV from the bloodstream and liver. Hepcinat LP is a preferred option for both treatment-naive and treatment-experienced patients, offering a well-tolerated and convenient therapeutic solution.

How to Use

Take one tablet of Hepcinat LP orally once daily with or without food. Swallow the tablet whole with a full glass of water. It is essential to adhere to the prescribed dosing schedule and complete the full course of treatment as directed by your healthcare provider. Do not crush, chew, or break the tablet before consumption.

How it Works

Ledipasvir and Sofosbuvir, the active ingredients in Hepcinat LP, target different stages of the HCV replication cycle. Ledipasvir inhibits the viral protein NS5A, essential for viral replication and assembly, while Sofosbuvir acts as a nucleotide analog inhibitor, disrupting the viral RNA polymerase enzyme. This dual mechanism of action effectively suppresses HCV replication, leading to viral clearance and improved liver function.

Dosage and Administration

The recommended dosage of Hepcinat LP is one tablet taken orally once daily with or without food. It is essential to follow the prescribed dosing regimen and complete the full course of treatment as directed by your healthcare provider to achieve optimal therapeutic outcomes.


  • Highly effective in treating chronic hepatitis C infections
  • Offers a convenient once-daily dosing regimen
  • Suitable for both treatment-naive and treatment-experienced patients
  • Achieves sustained virologic response (SVR) with high cure rates
  • Improves liver function and reduces the risk of liver-related complications

Common Side Effects

  • Headache
  • Fatigue
  • Nausea
  • Diarrhea
  • Insomnia

Common Concerns

  • Potential drug interactions with other medications
  • Adverse effects on kidney function
  • Development of drug-resistant viral strains
  • Monitoring for liver function abnormalities during treatment
  • Possibility of allergic reactions


  • Not recommended for use in patients with severe kidney impairment
  • Use with caution in patients with a history of hepatitis B virus infection
  • Risk of bradycardia when co-administered with amiodarone
  • Avoid use during pregnancy and breastfeeding

Storage Information

Store Hepcinat LP tablets at room temperature (20-25°C) away from moisture and heat. Keep the medication out of reach of children and pets.


Our sole intention is to ensure that its consumers get information that is expert-reviewed, accurate, and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover all possible side effects, drug interactions, or warnings or alerts. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

Additional Information


90 mg + 400 mg


28 Tablet/s, 56 Tablet/s, 84 Tablet/s

Pharma Form



Natco Pharma


Hepatitis C

Generic Brand

Ledipasvir & Sofosbuvir


There are no reviews yet.

Be the first to review “Hepcinat LP”